Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig L Slingluff

Showing results (31-40 of 225) with videos related to

Pageof 23
Sort By:
Journal for Immunotherapy of Cancer|June 28, 2014
Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanomaHoward L Kaufman, Carl E Ruby, Tasha Hughes, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2019
Tailoring early-phase clinical trial design to address multiple research objectivesNolan A Wages, Craig L Slingluff, Timothy N Bullock, et al.
Journal of Surgical Oncology|August 10, 2011
Surgical resection for bulky or recurrent axillary metastatic melanomaAmber L Shada, Dustin M Walters, Shannon N Tierney, et al.
The American Journal of Dermatopathology|July 26, 2014
Immunolabeling for p16, WT1, and Fli-1 in the assignment of growth phase for cutaneous melanomasAllen G Strickler, Jochen T Schaefer, Craig L Slingluff, et al.
International Journal of Cancer|June 19, 2025
Twenty-year survival outcomes after multipeptide vaccination for resected high-risk melanoma: A post-hoc analysis of a randomized clinical trialEmily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, et al.
Journal of Cutaneous Pathology|July 21, 2007
Extensive neurocristic hamartoma with skeletal muscle involvementChadrick E Denlinger, Craig L Slingluff, Martin C Mihm, et al.
Journal for Immunotherapy of Cancer|April 18, 2023
Barriers to immune cell infiltration in tumorsMarit M Melssen, Natasha D Sheybani, Katie M Leick, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
From bench to bedside a comprehensive review of pancreatic cancer immunotherapyPaul R Kunk, Todd W Bauer, Craig L Slingluff, et al.
Melanoma Research|June 28, 2017
Histopathologic review of negative sentinel lymph node biopsies in thin melanomas: an argument for the routine use of immunohistochemistryAnne M Stowman, Alexandra W Hickman, Alejandro A Gru, et al.
Cancers|November 27, 2024
Adverse Events as a Function of Biological Sex in a Multicenter Clinical Trial of Melanoma VaccinesCatherine E Lyons, Ruyun Jin, Aaron D Smith, et al.
Pageof 23

Showing results (31-40 of 225) with videos related to

Sort By:
Pageof 23
Journal for Immunotherapy of Cancer|June 28, 2014
Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanomaHoward L Kaufman, Carl E Ruby, Tasha Hughes, et al.
Cancer Immunology, Immunotherapy : CII|December 7, 2019
Tailoring early-phase clinical trial design to address multiple research objectivesNolan A Wages, Craig L Slingluff, Timothy N Bullock, et al.
Journal of Surgical Oncology|August 10, 2011
Surgical resection for bulky or recurrent axillary metastatic melanomaAmber L Shada, Dustin M Walters, Shannon N Tierney, et al.
The American Journal of Dermatopathology|July 26, 2014
Immunolabeling for p16, WT1, and Fli-1 in the assignment of growth phase for cutaneous melanomasAllen G Strickler, Jochen T Schaefer, Craig L Slingluff, et al.
International Journal of Cancer|June 19, 2025
Twenty-year survival outcomes after multipeptide vaccination for resected high-risk melanoma: A post-hoc analysis of a randomized clinical trialEmily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, et al.
Journal of Cutaneous Pathology|July 21, 2007
Extensive neurocristic hamartoma with skeletal muscle involvementChadrick E Denlinger, Craig L Slingluff, Martin C Mihm, et al.
Journal for Immunotherapy of Cancer|April 18, 2023
Barriers to immune cell infiltration in tumorsMarit M Melssen, Natasha D Sheybani, Katie M Leick, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
From bench to bedside a comprehensive review of pancreatic cancer immunotherapyPaul R Kunk, Todd W Bauer, Craig L Slingluff, et al.
Melanoma Research|June 28, 2017
Histopathologic review of negative sentinel lymph node biopsies in thin melanomas: an argument for the routine use of immunohistochemistryAnne M Stowman, Alexandra W Hickman, Alejandro A Gru, et al.
Cancers|November 27, 2024
Adverse Events as a Function of Biological Sex in a Multicenter Clinical Trial of Melanoma VaccinesCatherine E Lyons, Ruyun Jin, Aaron D Smith, et al.
Pageof 23